Dr. Reddy's Laboratories (RDY) reported fiscal Q4 earnings Friday of $0.22 per diluted share, up from $0.18 a year earlier.
One analyst polled by FactSet expected $0.20.
Revenue for the quarter ended March 31 was $996 million, up from $829 million a year earlier.
One analyst surveyed by FactSet expected $1.01 billion.
Shares of the company were up 1.8% in recent trading.
Price: 13.42, Change: +0.23, Percent Change: +1.78
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.